EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Refining Residual Ischemic Stroke Risk in Anticoagulated Atrial Fibrillation Using Index Outpatient LA Diameter: The CHA 2 DS 2 ‐VALa Score

Sefa Erdi Ömür iD, Emin Koyun iD, Gülşen Genç Tapar iD, Kayıhan Karaman iD, Metin Karayakali iD, Ataç Çelik iD, Uğur Kulu iD, Yasin Taşkin iD

Journal of Cardiovascular Electrophysiology · 2026-11 · 37 (11) · 2529-2540

DOI: 10.1111/jce.70431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 21.07.2026. Verfasst von Sefa Erdi Ömür und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tokat Gaziosmanpaşa University, Tokat, Turkey. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Stroke, Anticoagulants, Echocardiography. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) increases ischemic stroke risk nearly fivefold. Although the CHA 2 DS 2 ‐VA score is widely used for risk stratification, its predictive performance is limited, particularly in intermediate‐risk patients. Left atrial (LA) enlargement, a marker of structural remodeling, may improve risk prediction.

Aims

To evaluate whether adding LA diameter to CHA 2 DS 2 ‐VA (creating CHA 2 DS 2 ‐VALa) enhances ischemic stroke prediction in AF patients. We additionally derived a multivariable β‐weighted model and benchmarked its performance against CHA 2 DS 2 ‐VA (and the simplified +1 LA rule).

Methods

This retrospective study included 1648 AF patients. LA diameter was measured by standardized echocardiography. A ROC‐derived cut‐off (> 4.7 cm) defined enlargement. Patients were followed for a mean of 4.18 ± 0.35 years. Imaging‐confirmed ischemic stroke events were identified through institutional hospital records and the electronic health registry, and were validated using hospitalization documentation, neurology consultation notes, discharge summaries, and available brain CT/MRI findings. Predictors were assessed using multivariable logistic regression, and Kaplan–Meier/log‐rank analyses compared CHA 2 DS 2 ‐VALa versus CHA 2 DS 2 ‐VA.

Results

Imaging‐confirmed ischemic stroke events occurred more frequently in patients with LA > 4.7 cm (25 [3.8%] vs. 21 [2.1%], p < 0.001). Elevated CRP, NT‐proBNP, diabetes, hypertension, CAD, and heart failure were also associated with stroke. LA > 4.7 cm independently predicted events (OR 1.97, 95% CI 1.36–2.86, p < 0.001). ROC analysis showed strong discrimination for LA diameter (AUC 0.872; sensitivity 82%, specificity 85%). Kaplan–Meier analysis demonstrated superior prediction with CHA 2 DS 2 ‐VALa compared to CHA 2 DS 2 ‐VA (log‐rank p < 0.001).

Conclusion

The CHA 2 DS 2 ‐VALa score significantly improves stroke risk stratification in AF by integrating LA diameter into conventional scoring. As echocardiographic measurement is widely available and reproducible, this modification offers a simple, pragmatic approach to refine residual stroke‐risk stratification and support closer evaluation and follow‐up in anticoagulated AF patients. Prospective validation in diverse populations is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationIschemic StrokeAnticoagulantsEchocardiographyHeart AtriaAtrial RemodelingDecision Support TechniquesAtrial Function, LeftStrokeHumansFemaleMaleRetrospective StudiesRisk FactorsRisk AssessmentAgedPredictive Value of TestsMiddle AgedAged, 80 and overKaplan-Meier EstimateTime FactorsMultivariate AnalysisROC CurveTreatment Outcome

Stichwörter der Autor:innen

CHA2DS2‐VAatrial fibrillationechocardiographyleft atrium diameter

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Cardiology, Tokat Gaziosmanpaşa University, Tokat, Turkey.
  • Cardiology Clinic, Sivas State Hospital, Sivas, Turkey.
  • Department of Neurology, Tokat Gaziosmanpaşa University, Tokat, Turkey.
  • Department of Neurosurgery, Tokat Gaziosmanpaşa University, Tokat, Turkey.

ORCID-Profile: Sefa Erdi Ömür, Emin Koyun, Gülşen Genç Tapar, Kayıhan Karaman, Metin Karayakali, Ataç Çelik, Uğur Kulu, Yasin Taşkin

Zitieren

APA

Ömür, S. E., Koyun, E., Genç Tapar, G., Karaman, K., Karayakali, M., Çelik, A., Kulu, U., & Taşkin, Y. (2026). Refining Residual Ischemic Stroke Risk in Anticoagulated Atrial Fibrillation Using Index Outpatient LA Diameter: The CHA 2 DS 2 ‐VALa Score. Journal of Cardiovascular Electrophysiology, 37(11), 2529-2540. https://doi.org/10.1111/jce.70431

Vancouver

Ömür SE, Koyun E, Genç Tapar G, Karaman K, Karayakali M, Çelik A, et al. Refining Residual Ischemic Stroke Risk in Anticoagulated Atrial Fibrillation Using Index Outpatient LA Diameter: The CHA 2 DS 2 ‐VALa Score. Journal of Cardiovascular Electrophysiology. 2026;37(11):2529-2540. doi:10.1111/jce.70431

BibTeX
@article{mr2026,
  author = {Ömür, Sefa Erdi and Koyun, Emin and Genç Tapar, Gülşen and Karaman, Kayıhan and Karayakali, Metin and Çelik, Ataç and Kulu, Uğur and Taşkin, Yasin},
  title = {Refining Residual Ischemic Stroke Risk in Anticoagulated Atrial Fibrillation Using Index Outpatient LA Diameter: The CHA 2 DS 2 ‐VALa Score},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  volume = {37},
  number = {11},
  pages = {2529--2540},
  doi = {10.1111/jce.70431}
}
Kostenlos starten →